Company: CI
Filing Date: 2025-09-02
Form Type: S-3ASR
Source: 0001140361-25-033568
Chunk: 7

Company: Cigna Group
Filing Date: 2025-09-02
Form: S-3ASR
Chunk 7
---
 Cigna Group has previously filed with the SEC and that are not delivered with this prospectus. These documents contain important information about The Cigna Group and its financial condition. Since information that we file with the SEC in the future will update and supersede previously incorporated information, you should look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or any accompanying prospectus supplement or in any documents previously incorporated by reference have been modified or superseded.

| The Cigna Group SEC Filings (File No. 001-38769) 
 Annual Report on Form 10-K                       
 Quarterly Report on Form 10-Q                    |     | Period                                                                                                                                              
 For the year endedDecember 31, 2024(the “Annual Report”)                                                                                            
 For the quarters endedMarch 31, 2025andJune 30, 2025                                                                                                |
|:-------------------------------------------------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------|
| Annual Proxy Statement on Schedule 14A           |     | Filed onMarch 14, 2025(solely those portions that were incorporated by reference into Part III of the Annual Report)                                |
| Current Report on Form 8-K                       |     | Filed onMarch 13, 2025(excluding Item 7.01, which is furnished thereto),March 19, 2025,April 18, 2025,April 28, 2025,June 2, 2025, andJuly 28, 2025 |

We also incorporate by reference into this prospectus all documents filed by us under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after the date of this prospectus until the offering of the particular securities covered by a prospectus supplement has been terminated or completed, other than any portion of the respective filings that are furnished, rather than filed, under the applicable SEC rules. This additional information is a part of this prospectus from the date of filing of those documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: The Cigna Group Two Liberty Place, 1601 Chestnut Street Philadelphia, Pennsylvania 19192-1550 Attention: Shareholder Services Telephone: (215) 761-3516 E-mail: shareholderservices@evernorth.com Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference into